Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-13

Clinical Trial Update: Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brexpiprazole as an adjunct to sertraline for adults with post-traumatic stress disorder has completed and posted results. The study in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Sertraline)
  • brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Post Traumatic Stress Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-06-13